The Rise in Robotic Atypical Segmentectomies
The Rise in Robotic Atypical Segmentectomies: A Large Cancer Center Experience
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- No age limits stated
- Sex
- All sexes
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
Not stated in the study description — ask the study team about visits and procedures.
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study reviews past patient records to see if robotic surgery has led to more atypical segmentectomies, which remove a section of a lung lobe. It includes people who had surgery to remove lung tissue from 2004 to 2019.
This study investigates the increased rate of robotic atypical segmentectomies. Segmentectomy refers to removing a section of a lobe of the lung. Reviewing patients' data retrospectively may help researchers determine whether robotic surgery has led to an increase in atypical segmentectomy.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- Had surgery to remove lung tissue from 2004 to 2019.
Who can't join
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Inclusion Criteria: * Patients who underwent a lung resection from 2004 to 2019
Study sites (1)
TX
- M D Anderson Cancer Center · Houston, TX 77030David C. Rice · Study contact · 713-563-9153David C. Rice · Principal investigatorMore trials in Houston